The Valley Desk

NCT04755283 · Interventional trial

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

Overall registry status Active not recruiting

Phase 2

Conditions Atrial Fibrillation (AF), Stroke

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov